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Abstract 18 
With the aim of optimizing the cloning of novel genes from a genomic pool containing many 19 
previously identified, homologous, genes we designed a redundant exclusion PCR technique. In 20 
RE-PCR a pair of generic amplification primers are combined with additional primers that are 21 
designed to specifically bind to redundant, unwanted genes that are a subset of those copied by the 22 
amplification primers. During RE-PCR the specific primer blocks amplification of the full length 23 
redundant gene. Using this method we managed to clone a number of cry8 or cry9 toxin genes 24 
from a pool of Bacillus thuringiensis genomic DNA while excluding amplicons for cry9Da, 25 
cry9Ea and cry9Eb. The method proved very efficient at increasing the number of rare genes in 26 
the resulting library. One such rare, and novel, cry8-like gene was expressed and the encoded 27 
toxin was shown to be toxic to Anomola corpulenta. 28 
Importance 29 
Protein toxins from the bacterium Bacillus thuringiensis are being increasingly used as 30 
biopesticides against a wide range of insect pests, yet the search for new or improved toxins is 31 
becoming more difficult as traditional methods for gene discovery routinely isolate previously 32 
identified clones. This paper describes an approach that we have developed to increase the success 33 
rate for novel toxin gene identification through reducing or eliminating the cloning of previously 34 
characterized genes.  35 
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Introduction 36 
As a result of the proteinaceous insecticidal toxins produced by Bacillus thuringiensis (Bt) 37 
this bacterium has become a commercially successful biopesticide [1]. Products based on Bt 38 
include formulations of the bacterium itself or the toxin expressed in an alternative host – in 39 
particular genetically modified crops [2]. Despite the increasing use of these products there 40 
remains a need to discover new toxins with desirable properties - such properties include an 41 
increased activity against a given target, activity against a new target pest or the ability to control a 42 
pest that has developed resistance to an existing toxin. A number of different approaches can be 43 
used to identify novel toxins, the traditional one being to screen strains for a desired activity and 44 
then isolate the active ingredient. In recent times molecular approaches have been increasingly 45 
used including genome sequencing [3] and PCR techniques. The latter rely on there being 46 
conserved regions present in toxin gene families as well as the more variable regions that give 47 
toxins their individual characteristics [4]. Improved PCR procedures have allowed the successful 48 
cloning of Bt toxin genes from complex DNA mixtures prepared from pooled samples [5, 6]. A 49 
problem with this sort of approach however is the high ratio of known or undesired toxin genes in 50 
libraries made from these pooled samples which has made the discovery of new genes 51 
increasingly difficult.  52 
B. thuringiensis Cry8 and Cry9 proteins have significantly different insecticidal spectra 53 
despite phylogenetic analyses indicating that they share high sequence similarity in domains I and 54 
II [7, 8]. Cry8 proteins are toxic to Coleopteran insects while Cry9s have high activity to 55 
Lepidopteran insects [9-12], both are valuable toxins for insect pest management. This paper 56 
describes a procedure developed to analyse cry8 and cry9 genes in a DNA pool prepared from 57 
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2000 Bt strains and used to efficiently clone novel isolates.  58 
Materials and methods 59 
Bacterial strains, plasmids, and growth conditions  60 
Bt stains were isolated from soil samples in China as described previously [6]. E. coli DH5α 61 
was used for standard transformations, whilst E.coli SCS110 (RpsL [strr], thr, leu, endA, thi-1, 62 
lacY, galK, galT, ara, tonA, tsx, dam, dcm, upE44, D [lac-proAB] [F0 traD36 proAB 63 
lacIqZDM15]) was used to produce non-methylated plasmid DNA for transformation of HD73-, a 64 
crystal-negative mutant strain of Bt. 65 
The cloning vector pEB was constructed by inserting the pETblue-2 expression region into 66 
the StyI-BglII sites of pET-21b. Plasmid pSTK containing the cry3Aa promoter and STAB-SD 67 
sequence was constructed by Wang et al. [13] and used to express cry genes in HD73-. 68 
E.coli was incubated at 37°C in LB medium (1% NaCl, 1% tryptone, and 0.5% yeast extract), 69 
and Bt strains were grown at 30°C on LB agar (1% NaCl, 1% tryptone, 0.5% yeast extract and 70 
1.3%-1.5% agar). To select antibiotic-resistant E.coli and Bt strains, ampicillin and kanamycin 71 
were added to the culture medium at a final concentration of 100 μg/ml and 50 μg/ml respectively. 72 
All of the cultures were incubated in a rotary shaker at 220 rpm. 73 
Identification of cry8 and cry9 genes from pooled genomic DNA 74 
Pooled genomic DNA was prepared from 2000 Bt strains as described by Li et al [6] and 75 
used as the template for PCR. A pair of universal primers cry_F and cry_R (Table 1) were 76 
designed based on an alignment of cry8 and cry9 holotype genes and were used to amplify the 77 
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toxin coding region of these genes. A 50 μl PCR mixture contained 100 ng template DNA, 25 μl 78 
2×PrimeSTAR master mix (TaKaRa, Dalian, China), and 0.2 μmol-l of each primer. The reaction 79 
consisted of an initial denaturation step of 94°C for 5 min, 30 cycles of 94°C for 1min; 54°C for 80 
1min; 72°C for 2 min 20 s, and final extension step of 72°C for 10 min. The resulting PCR 81 
product was purified using a DNA gel extraction kit (AXYGEN, Hangzhou, China) and ligated 82 
into the Ecl136II site of the pEB vector. 83 
The cry9 and cry8 genes in the pooled DNA were classified by PCR-RFLP analysis. Genes 84 
were amplified from library clones using cry_F and cry_R, digested with Hinf I, and then profiled 85 
by 2% agarose gel electrophoresis. Clones with different restriction length fragment 86 
polymorphism (RFLP) profiles were selected for sequencing. 87 
Redundant Exclusion PCR  88 
Primers RE9Da_F and RE9Ea/b_F (Table 2) were designed to specifically hybridize to 89 
cry9Da, and to cry9Ea/cry9Eb respectively. Test reactions were performed in 20 μL total volume 90 
containing 10 ng of cry9Ea and cry9Eb or cry9Da-encoding plasmid DNA, 0.2 μmolL-l primer 91 
RE9Da_F or RE9Ea/b_F, 0.2 μmol L-l of primer cry_F and/or cry_R, and 10 μl 2×PrimeSTAR 92 
master mix. PCR consisted of an initial denaturation step of 94°C for 5 min, 30 cycles of 94°C 93 
1min; 54°C 1min; 72°C, 2 min 20 s, and a final extension step of 72°C for10 min.  94 
Expression of the cry8-like gene 95 
To express the truncated cry8-like gene in Bt, a seamless assembly cloning method was used 96 
to fuse the truncated gene to DNA encoding the Cry8Ea C-terminal coding region. The primers 97 
designed to amplify these two sections, with appropriate overlaps, are listed in Table 3. A 10 μL 98 
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reaction mix containing 20 ng pSTK plasmid (linearized with BamHI+SalI), 30 ng each of the 99 
PCR products and 5 μL 2×Assembly Master Mix (Seamless Assembly Cloning kit, CloneSmarter, 100 
USA）was incubated at 50°C for 10 min. After transformation of E. coli DH5α the resulting hybrid 101 
(hycry8) was sequenced using an automated DNA sequencer (ABI-3730XL, USA). The 102 
recombinant plasmid, isolated from E.coli, was used to transform SCS110 prior to introduction 103 
into Bt strain HD73- by electroporation. A single transformant was selected from LB plates 104 
containing kanamycin (50 g/ml) and incubated until sporulation at 30°C. The spore-crystal 105 
mixture was washed and re-suspended in sterile distilled water, and the suspension was examined 106 
by microscopy and SDS-PAGE analysis according to Shu et al [14]. For proteolytic activation the 107 
toxin crystals were solubilized in 50mM Na2CO3 pH10 and then treated with chymotrypsin (10:1 108 
w/w) in PBS and incubated at 37°C for 2 h. 109 
Insect bioassay 110 
The insecticidal activity of spore-crystal mix from the recombinant Bt strain was tested 111 
against larvae of 15-day-old Anomala corpulenta, 5-day-old Holotrichia parallela, and 5-day-old 112 
Holotrichia oblita. The bioassay diet for these scarab larvae was prepared as described by Yu et al 113 
[15]. For initial screening, we used a concentration of 1.0×108 colony forming units (CFU) g−1soil. 114 
Further assays were performed with samples showing toxicity to any of the pests in order to 115 
determine LC50 values. Bioassays were repeated at least twice, and LC50 values were calculated 116 
using probit analysis. 117 
  118 
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Results 119 
Identification of cry8 and cry9 genes from pooled genomic DNA 120 
A library of 2.1 kb PCR products encoding the active portion of cry8/9 toxin genes (Fig.1A 121 
lane1), produced from the pooled genomic DNA using primers cry_F and cry_R, was created and 122 
subjected to PCR-RFLP analysis. Two hundred clones were tested and four distinct profile types 123 
were detected (Fig.1B lane1-4). Representatives of these were sequenced and this indicated that 124 
the four profiles belonged to cry9Da (100% identity to cry9Da4, accession number: GQ249297.1), 125 
cry9Ea (99% identity to cry9Ea9, accession number: JN651495.1), cry9Eb (99% identity to 126 
cry9Eb2, accession number: GQ249298.1) and a new cry8-like (86% identity to cry8Ab1, 127 
accession number: EU044830.1). Figure 2 (solid bars) shows the relative frequency of these four 128 
profiles, 70% of the clones matched the cry9Ea profile while 5% matched cry8-like. 129 
Redundant Exclusion primer PCR 130 
To exclude known genes from the library we relied on the fact that the high fidelity 131 
polymerase that we used in our PCR reactions (PrimeSTAR GXL) lacks a 5’-3’ exonuclease 132 
activity and so polymerization can be halted by the presence of a bound oligonucleotide. We 133 
designed primers that would specifically, and tightly, bind to particular cry8/9 genes and thus 134 
prevent amplification of the full PCR product by the primers. The primers RE9Da_F and 135 
RE9Ea/b_F (Tables 2 and 4) were designed to hybridize to variable regions in domain II of 136 
cry9Da and cry9Ea/9Eb respectively. A number of PCRs were run to test these primers. When the 137 
two amplification primers and the two redundant exclusion primers were all included in a 138 
multiplex PCR (Fig1A lane 2) two distinct bands are seen, the 2.1kb band represents the full 139 
8 
 
length products amplified by cry_F and cry_R while the approximately 750 bp band represents the 140 
fragment of the gene amplified by RE9Da_F/RE9Ea/b_F and cry_R. The source of this 750 bp 141 
band was confirmed in separate reactions involving just an RE primer and cry_R (Fig 1A lanes 3 142 
and 4). To confirm that the RE primers could block amplification of the corresponding gene pairs 143 
of reactions were performed using specific genes as templates. Figure 1A lanes 5-8 show that 144 
amplification of the full length gene is completely (cry9Da lane 8) or mostly (cry9Ea/b lane 6) 145 
inhibited by the appropriate RE primer.  146 
A new library was created from the 2.1kb PCR product produced using cry_F and cry_R 147 
from pooled DNA but this time including the RE primers in the amplification reaction. A total of 148 
200 clones were analyzed by PCR-RFLP and this time five different profiles were obtained 149 
(Fig.1B lanes 3-7). Two of these profiles (cry9Ea and cry8-like) were the same as previously 150 
identified while the other three corresponded to cry8Fa (99% identity to cry8Fa2, accession 151 
number HQ174208.1), cry8Ab-like (99% identity to cry8Ab1-like, accession number: JF521572.1) 152 
and cry8Ea (99% identity to cry8Ea1, accession number: AY329081.1). Although the cry9Ea 153 
profile was detected despite the presence of the corresponding RE primer its frequency had 154 
dropped dramatically (Figure 2 open bars). The cry9Da and cry9Eb profiles had successfully been 155 
excluded. In contrast the frequency of the cry8-like profile rose significantly.  156 
Expression of the novel cry8-like gene 157 
The cry_F and cry_R primers were designed to amplify the active toxin portion of the cry8/9 158 
genes but not the region encoding the C-terminal crystallization domain [4]. To express a complete 159 
toxin we added this C-terminal region from a homologous gene, cry8Ea. Figure 3 shows the 160 
sequence of the Cry8-like toxin and the resulting hybrid (hyCry8). The hybrid gene was 161 
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sub-cloned into pSTK and introduced into HD73- for expression. The hyCry8 protein expressed 162 
well in this host (Fig.4C lane 2) and accumulated as spherical crystals (Fig.4B).When the protoxin 163 
was treated with chymotrypsin (Fig.4C lane 3), a 60 kDa protein was obtained as expected [16].  164 
Insect bioassay 165 
To evaluate the toxicity of the hybrid protein, spore/crystal mix of the recombinant Bt strain 166 
was tested for insecticidal activity on larvae of 15-day stage A.corpulenta, 5-day stage H.parallela, 167 
and 5-day stage H.oblita. At a concentration of 1.0×108 CFU g-1 soil the parent strain HD73- had 168 
no insecticidal activity against any of the three bioassayed insects. The strain expressing the 169 
hybrid was shown to be toxic to A.corpulenta larvae (Fig.5) but not to H.parallela or H.oblita.  170 
Discussion 171 
In recent years many research projects have focused on cloning desired genes from complex 172 
DNA samples (metagenomic or pooled DNA) [5, 6, 17-19]. In such samples the distribution of 173 
gene homologues can be unequal and it can be a difficult task to isolate rare forms. Here we have 174 
demonstrated the use of redundant exclusion PCR to remove unwanted homologues from a gene 175 
pool and thus increase the frequency of rare forms in an amplicon library.  176 
Bt is an insect pathogen which during sporulation produces insecticidal proteins that 177 
accumulate in the mother cell and form intracellular parasporal crystals [1, 20]. These crystals 178 
contain toxins, encoded by cry genes, which are noted for their specific insecticidal activity. Cry 179 
proteins have been expressed in crops to control agricultural pests [21, 22]. Due to their 180 
commercial value much research has focused on toxin gene discovery and here we have 181 
demonstrated the use of an RE-PCR based method that can identify new and rare cry gene 182 
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homologues from a genomic DNA pool and identified a novel toxin with activity against an 183 
economically important pest. The method relies on us being able to identify unique regions in 184 
redundant genes and would therefore exclude any otherwise novel genes that happened to share 185 
that region. Nonetheless we have demonstrated that the principle works well and alternative RE 186 
primers can always be designed in an attempt to overcome this potential limitation. The fact that 187 
some cry9Ea profiles could still be detected may represent the fact that this process is not 100% 188 
efficient and so there can be some background, which will be particularly noticeable for high 189 
abundance genes. Alternatively polymorphisms in the RE primer region could allow amplification 190 
of these variants. 191 
The toxin that we identified by this method is closely related to other Cry8 toxins, 192 
comparison of the active toxin region with all toxins in the nomenclature reveals that the closest 193 
match is to Cry8Ab1 with 79% identity. This level of identity is sufficient to consider the toxin 194 
novel - studies have shown that just a few amino acid differences in a toxin can not only determine 195 
whether or not it is toxic, but also to which insect it has toxicity [23]. This conclusion is supported 196 
by our bioassay data: the variant that we have isolated shows activity to A. corpulenta but not to H. 197 
oblita or H. parallela. This contrasts with Cry8N which showed activity against the latter insect 198 
but not the former two [24], with Cry8Ga which has activity against the two Holotrichia species 199 
but not A. corpulenta [12], Cry8Ab with activity against the two Holotrichia species [25] and with 200 
Cry8Fa and another Cry8-like protein that have activity against none or all of these three species 201 
respectively [10, 11]. Thus on both sequence and insect specificity levels this newly described 202 
toxin has novel attributes which have potential not only for the control of these insects but also in 203 
the understanding of specificity determination. It should be noted that our bioassays were 204 
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conducted on a hybrid toxin in which the C-terminal region was provided by another toxin. While 205 
the C-terminal region of the larger Cry toxins is known to be important for toxin 206 
expression/packaging [26] and may influence toxicity [27] there is no convincing evidence that it 207 
influences specificity and thus we believe that it is reasonable to attribute the observed activity to 208 
the newly cloned portion of the toxin. 209 
In conclusion, the RE-PCR based approach developed in this paper was able to effectively 210 
exclude undesired homologue genes but clone low frequency genes from a complex DNA sample. 211 
It is particularly applicable to families of homologous genes where there are known areas with 212 
variation that can be used for the design of the RE primers, the method should be suitable for other 213 
samples such as metagenomic DNA. 214 
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Table 1 Homologues of cry9 and cry8 genes and the design of universal amplification primers. 301 
Primers and Genes Sequence Location Genbank Acc 
 number 
cry_F ATGAATCGAAATAATCAAAATGAATAT   
cry9Bb1 ATGAATCGAAATAATCAAAATGAATAT 1~27 X75019.1 
cry9Ca1 ATGAATCGAAATAATCAAAATGAATAT 1~27 Z37527.1 
cry9Da1 ATGAATCGAAATAATCAAAATGAATAT 1~27 D85560.1 
cry9Db1 ATGAATCGAAATcATCAAAATGAATAT 1~27 AY971349.1 
cry9Dc1 ATGAATCGAAATAATCAAAATGAATAT 1~27 KC156683.1 
cry9Ea1 ATGAATCGAAATAATCcAAATGAATAT 1~27 AB011496.1 
cry9Eb1 ATGAAcCGAAATAATCAAAATGAtTAT 1~27 AX189653.1 
cry9Ec1 ATGAATCGAAATAATCAAAATGAATAT 1~27 AF093107.2 
cry9Ed1 ATGAATCGAAATAATCAAAATGAATAT 1~27 AY973867.1 
cry9Ee1 ATGAATCGAAATAATCAAAATGAATAT 1~27 GQ249296.1 
cry9Fa1 ATGAcTaGAAATAgACAAgATGAATAT 1~27 KC156692.1 
cry8Aa1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 U04364.1 
cry8Ab1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 EU044830.1 
cry8Ac1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 KC156662.1 
cry8Ad1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 KC156684.1 
cry8Ba1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 U04365.1 
cry8Bb1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 AX543924.1 
cry8Bc1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 AX543926.1 
cry8Ca1 ATGAgTCgAAATAATCAAAATGAgTAT 1~27 U04366.1 
cry8Db1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 AB303980.1 
cry8Ea1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 AY329081.1 
cry8Fa1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 AY551093.1 
cry8Ga1 ATGAgTCcgAATAATCAgAAcGAATAT 1~27 AY590188.1 
cry8Ha1 ATGAaTCcgAATAATCAgAATGAATAT 1~27 AY897354.2 
cry8Ia1 ATGAgTCcgAATAATCAgAATGAgTtT 1~27 EU381044.1 
15 
 
cry8Ib1 ATGAgcCcAAATAATCAAAATGAgTtT 1~27 GU325772.1 
cry8Ja1 ATGAgTCcgAATAATCAgAATGAgTAT 1~27 EU625348.1 
cry8Ka1 ATGAgTCcAAATAATCtAAATGAATAT 1~27 FJ422558.1 
cry8Kb2 ATGAgTCcAAATAATCAAAATGAATAT 1~27 FJ770570.1 
cry8Na1 ATGAgTCcgAATAATCAAAAcGAATAT 1~27 HM640939.1 
cry8Pa1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 HQ388415.1 
cry8Qa1 ATGAgTCcAAATAATCAAAATGAATAT 1~27 HQ441166.1 
cry8Ta1 ATGAgTCaAAATAATCAAAATGAATAT 1~27 KC156673.1 
cry_R GATAAGCAYGACACTAAATTTGC   
cry9Bb1 GCAAATTTAGTGTtATGCTTATC 2110~2132 X75019.1 
cry9Ca1 GCAAATTTAGTGTCATGCTTATC 2092~2114 Z37527.1 
cry9Da1 GCAAATTTAGTGTCATGCTTATC 2125~2147 D85560.1 
cry9Db1 GCAAATTTAGTGTCATGCTTATC 2128~2150 AY971349.1 
cry9Dc1 GCAAATTTAGTGTCGTGCTTATC 2125~2147 KC156683.1 
cry9Ea1 GCAAATTTAGTGTCGTGCTTATC 2071~2093 AB011496.1 
cry9Eb1 GCAAATTTAGTGTCATGCTTATC 2074~2096 AX189653.1 
cry9Ec1 GCAAATTTAGTGTCATGCTTATC 2083~2105 AF093107.2 
cry9Ed1 GCAAATTTAGTGTCGTGCTTATC 2083~2105 AY973867.1 
cry9Ee1 GCAAATTTAGTGTCGTGCTTATC 2089~2111 GQ249296.1 
cry9Fa1 GCAAATTTAGTGTCATGCTTAaC 2089~2111 KC156692.1 
cry8Aa1 GCAAAcTTAGTGgaATGCcTATC 2104~2126 U04364.1 
cry8Ab1 GCAAAcTTAGTGgaATGCcTATC 2122~2144 EU044830.1 
cry8Ac1 GCAAAcTTAGTGgaATGCcTATC 2146~2168 KC156662.1 
cry8Ad1 GCcAAcTTAGTGgaATGCcTATC 2104~2126 KC156684.1 
cry8Ba1 GCcAAcTTAGTGgaATGCcTATC 2092~2114 U04365.1 
cry8Bb1 GCAAAcTTAGTGgaATGCcTATC 2107~2129 AX543924.1 
cry8Bc1 GCAAAcTTAGTGgaATGCcTATC 2119~2141 AX543926.1 
cry8Ca1 GCAAAcTTAaTagaATGCcTATC 2095~2117 U04366.1 
cry8Db1 GCAAAcTTAGTagaATGCcTATC 2137~2159 AB303980.1 
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cry8Ea1 GCAAAcTTAGTGgaATGCcTATC 2074~2096 AY329081.1 
cry8Fa1 GCAAAcTTAGTGgaATGCcTATC 2104~2126 AY551093.1 
cry8Ga1 GCAAAcTTAGTagaATGCcTATC 2087~2109 AY590188.1 
cry8Ha1 GCtAATTTAGTagaATGCcTATC 2089-2111 AY897354.2 
cry8Ia1 GCAAATTTAaTtgaATGCgTATC 2113~2135 EU381044.1 
cry8Ib1 GCAAATTTAaTtgaATGCgTATC 2156~2138 GU325772.1 
cry8Ja1 GCAAAcTTAaTagaATGCcTATC 2101~2123 EU625348.1 
cry8Ka1 GCAAAcTTAGTcgaATGCcTATC 2086~2108 FJ422558.1 
cry8Kb2 GCcAAcTTAGTGgaATGCcTATC 2092~2114 FJ770570.1 
cry8Na1 GCAAAcTTAGTagaATGCcTATC 2104~2126 HM640939.1 
cry8Pa1 GCAAAcTTAGTcgaATGCcTATC 2095~2117 HQ388415.1 
cry8Qa1 GCAAAcTTAGTcgaATGCcTATC 2119~2141 HQ441166.1 
cry8Ta1 GCAAATTTAaTtgaATGCgTATC 2149~2171 KC156673.1 
 302 
  303 
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Table 2 Homologues of cry9 and cry8 genes and the design of redundant exclusion primers. 304 
Primers and 
Genes 
Sequence Location Genbank Acc 
number 
RE9Da_F AGGATATACACAGCAAGGTATACC AGC   
cry9Bb1 --AACGAA------CTTTGTTA------ 1346~1359 X75019.1 
cry9Ca1 --GACTTC----TCCTGCTAATGG-AGG 1323~1343 Z37527.1 
cry9Da1 AGGATATACACAGCAAGGTATACC-AGC 1347~1373 D85560.1 
cry9Db1 -GGACAAA---ATAACGTTCTTCC-ACA 1366~1388 AY971349.1 
cry9Dc1 -GGACAAA---ATAACGTTTTGCC-ACC 1366~1388 KC156683.1 
cry9Ea1 --CACCAA----TGCAGCTAATAC-GTG 1335~1355 AB011496.1 
cry9Eb1 --CACCTC----AGCCCCTAATAC-GTG 1335~1355 AX189653.1 
cry9Ec1 --CATTTC----TCCTGCTAATGC-AGG 1332~1352 AF093107.2 
cry9Ed1 --CATTTC----TCCTGCTAATGC-AGG 1332~1352 AY973867.1 
cry9Ee1 --GACTCA----ACCTTCTACTGG-AGG 1332~1352 GQ249296.1 
cry9Fa1 --GTCAAC-----CCACCTAATTC-TGG 1345~1364 KC156692.1 
cry8Aa1 TATATTCAAAAACACATACAGCTCTCCA 1346~1373 U04364.1 
cry8Ab1 TTTATTCTAAAACACATACAACTGGAGA 1349~1376 EU044830.1 
cry8Ac1 TTTATTCTAAAACATATACAACTCCAAA 1349~1376 KC156662.1 
cry8Ad1 TTTATTCAAAAACACATACAACTCCATA 1343~1370 KC156684.1 
cry8Ba1 AACGTATAAACCAGCTTCCAAAGATATT 1347~1374 U04365.1 
cry8Bb1 AAAGTATAATCCAGTTTCCAAAGATATT 1347~1374 AX543924.1 
cry8Bc1 AAAGTATAATCCGGTTTCCAAAGATATT 1347~1374 AX543926.1 
cry8Ca1 CTTAT-TCGAAGCCAAAACAATTC-GCG 1322~1347 U04366.1 
cry8Db1 CGTACTCAAAACCACATACAACTATGCA 1352~1379 AB303980.1 
cry8Ea1 CCTATAAT-----CCTG-GATCTGAAGG 1328~1379 AY329081.1 
cry8Fa1 CTCATTTTTTCTGATAG-TACGGGAGGG 1330~1357 AY551093.1 
cry8Ga1 GGTATCAAAAAGAATCTA-ATGTC-CCA 1322~1347 AY590188.1 
cry8Ha1 TGGATACGATATAGCGTTTAGCGAAA-- 1332~1357 AY897354.2 
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cry8Ia1 TAATTATGAACCTCCAGGCATATCCA-A 1329~1355 EU381044.1 
cry8Ib1 TGAATATGATCTTCAACTTTTGTCTA-A 1332~1358 GU325772.1 
cry8Ja1 TTTACCTATAATCCTGGATCTGAA-GGT 1324~1350 EU625348.1 
cry8Ka1 ATGAAAAAT-----TATCGAACTT---- 1328~1346 FJ422558.1 
cry8Kb2 ATGAAAAAT-----CATCGAACTT---- 1328~1346 FJ770570.1 
cry8Na1 TCTATCTTGTGGGGTG-----GTG-C-- 1354~1373 HM640939.1 
cry8Pa1 AGTGTATAAGCCGGTTTCCAAAGATATT 1341~1368 HQ388415.1 
cry8Qa1 CTCACTTTCTCTGATAGTACGGGCGGAA 1327~1354 HQ441166.1 
cry8Ta1 CGTATAGTAAAACCCATACAGCTATACA 1346~1373 KC156673.1 
RE9Ea/b_F GAAAT         CACCAA     TGCAGCTAATAC GT   
cry9Bb1 AACTC--------AACGAA------CTTTGTTA---- 1341~1359 X75019.1 
cry9Ca1 GGTAC--------GACTTC----TCCTGCTAATGG-AG 1318~1342 Z37527.1 
cry9Da1 GGGATT---TCAGGATATACACAGCAAGGTATACC-AG 1339~1372 D85560.1 
cry9Db1 CGTATG---TC-GGACAAA---ATAACGTTCTTCC-AC 1358~1379 AY971349.1 
cry9Dc1 CGTATG---TC-GGACAAA---ATAACGTTTTGCC-AC 1358~1379 KC156683.1 
cry9Ea1 GAAAT--------CACCAA----TGCAGCTAATAC-GT 1330~1354 AB011496.1 
cry9Eb1 GAAAT--------CACCTC----AGCCCCTAATAC-GT 1330~1354 AX189653.1 
cry9Ec1 GGTAC--------CATTTC----TCCTGCTAATGC-AG 1327~1351 AF093107.2 
cry9Ed1 GGTAC--------CATTTC----TCCTGCTAATGC-AG 1327~1351 AY973867.1 
cry9Ee1 GGCAC--------GACTCA----ACCTTCTACTGG-AG 1327~1351 GQ249296.1 
cry9Fa1 AGTGTT-------GTCAAC-----CCACCTAATTC-TG 1363~1387 KC156692.1 
cry8Aa1 AACAGCGTATTTATATTCAAAAACACATACAGCTCTCC 1335~1372 U04364.1 
cry8Ab1 ATCATCTCATCTTTATTCTAAAACACATACAACTGGAG 1338~1375 EU044830.1 
cry8Ac1 ATCAACTCAACTTTATTCTAAAACATATACAACTCCAA 1338~1375 KC156662.1 
cry8Ad1 ATCATATTATTTTTATTCAAAAACACATACAACTCCAT 1332~1369 KC156684.1 
cry8Ba1 AAGACG---TTAACGTATAAACCAGCTTCCAAAGATAT 1339~1373 U04365.1 
cry8Bb1 AAGACG---TTAAAGTATAATCCAGTTTCCAAAGATAT 1339~1373 AX543924.1 
cry8Bc1 AAGACG---TTAAAGTATAATCCGGTTTCCAAAGATAT 1339~1373 AX543926.1 
cry8Ca1 AAAAA-----ACTTAT-TCGAAGCCAAAACAATTC-GC 1316~1347 U04366.1 
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cry8Db1 GGTTTT----ACGTACTCAAAACCACATACAACTATGC 1345~1378 AB303980.1 
cry8Ea1 AACATT---TACCTATAAT-----CCTG-GATCTGAAG 1320~1348 AY329081.1 
cry8Fa1 TGCACACA-CCCTCATTTTTTCTGATAG-TACGGGAGG 1320~1355 AY551093.1 
cry8Ga1 GACCTT---TAGGTATCAAAAAGAATCTA-ATGTC-CC 1314~1347 AY590188.1 
cry8Ha1 GGGATTGATGTTGGATACGATATAGCGTTTAGCGAAA- 1321~1357 AY897354.2 
cry8Ia1 GGGAA----TTTAATTATGAACCTCCAGGCATATCCA- 1322~1344 EU381044.1 
cry8Ib1 TAGAT----TATGAATATGATCTTCAACTTTTGTCTA- 1325~1357 GU325772.1 
cry8Ja1 AACAAC----ATTTACCTATAATCCTGGATCTGAA-GG 1317~1349 EU625348.1 
cry8Ka1 GAGTTACATGTATGAAAAAT-----TATCGAACTT--- 1317~1346 FJ422558.1 
cry8Kb2 GAGTTACAGGTATGAAAAAT-----CATCGAACTT--- 1317~1346 FJ770570.1 
cry8Na1 GGCCAC---GTTCTATCTTGTGGGGTG-----GTG-C- 1346~1373 HM640939.1 
cry8Pa1 AAG------TTAGTGTATAAGCCGGTTTCCAAAGATAT 1336~1367 HQ388415.1 
cry8Qa1 TGCCCCCA-ATCTCACTTTCTCTGATAGTACGGGCGGA 1317~1353 HQ441166.1 
cry8Ta1 TGGCTCCCTTACGTATAGTAAAACCCATACAGCTATAC 1335~1372 KC156673.1 
20 
 
Table 3 Amplification Primers 306 
Primer Sequence (5'to3') 
hycry8_F 
hycry8_R 
hycry8Ea_F 
hycry8Ea_R 
TGGTGGACAGCAAATGGGTCGGGATCCGATGAATCGAAATAATC 
CATTTGGATACAAATCATCCGATAAGCATGACACTAAATTTGCCGC 
GGATGATTTGTATCCAAATG 
CTCGAGTGCGGCCGCAAGCTTGTCGACTTACTCTACGTCAACAATC 
 307 
 308 
  309 
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Table 4 Primers and Annealing Temperatures 310 
 311 
 312 
  313 
Primers A-base 
content 
C-base 
content 
G-base 
content 
T-base 
content 
length（bps） TM（℃） 
REDa_F 40.7% 22.2% 22.2% 14.8% 27 62.0 
RE9Ea/b_F 27.6% 17.2% 27.6% 27.6% 29 68.0 
cry_F 55.6% 7.4% 11.1% 25.9% 27 57.7 
cry_R 39.1% 21.7% 17.4% 21.7% 23 55.2 
22 
 
Fig.1 PCR product restriction fragment length polymorphism profiles of cloned genes.  314 
A:Lane1: PCR product from pooled genomic DNA and cry_F/cry_R primers; Lane2: PCR product 315 
from pooled genomic DNA, cry_F/cry_R and REcry9Da_F/ REcry9Ea/b_F primers; Lane3: PCR 316 
product from pooled genomic DNA and REcry9Da_F/cry_R primers; Lane4: PCR product from 317 
pooled genomic DNA and REcry9Ea/b_F and cry_R primers; Lane5: PCR product from cry9Ea 318 
and cry9Eb template and cry_F/cry_R primers；Lane6: PCR product from cry9Ea and cry9Eb 319 
template, cry_F/cry_R and REcry9Ea/b_F primers；Lane7: PCR product from cry9Da template, 320 
cry_F/cry_R；Lane8: PCR product from cry9Da template cry_F/cry_R and REcry9Da_F primers; 321 
M: molecular weight marker (DL5000). 322 
B: Lanes1-7:RFLP profile of cloned cry9Eb, cry9Da, cry9Ea, cry8-like, cry8Fa, cry8Ab-like, 323 
cry8Ea genes. M: molecular weight marker (DL2000). 324 
 325 
Fig.2 The proportion of clones in the genomic libraries. The solid bars represent clones isolated 326 
from the normal library while the open bars represent those from the redundant exclusion library. 327 
 328 
Fig.3 Amino acid alignment of Cry8Ab1, Cry8-like, hyCry8 and Cry8Ea. 329 
 330 
Fig.4 SEM and SDS-PAGE analysis of spore/crystal mixtures. A: Bt strain HD73-; B: Bt strain 331 
expressing hyCry8; C: SDS-PAGE. M: protein marker; lane1: HD73-; lane2: hyCry8; lane3: 332 
chymotrypsin-treated hybrid. 333 
 334 
Fig.5 Insecticidal activity of a spore/crystal mixture of the hybrid expressing strain 335 





